Medicare News and Research

RSS

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

Eli Lilly and Company today announced that a total of 14 U.S. and global studies involving its osteoporosis medications, FORTEO® [teriparatide (rDNA origin) injection] and EVISTA® (raloxifene HCl tablets), will be presented at the American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting from October 15-19 in Toronto, ON, Canada.

18 Oct 2010

First Edition: October 18, 2010

Today's news includes continuing coverage of the run-up to the mid-term elections and how health reform is playing in the discourse.

18 Oct 2010

Politics and health law: Dems' divergent strategies; mixed polls on 'repeal and replace'

Some Democratic candidates are defending their votes, or refining their message, as news outlets cover the health reform aspects of the campaigns.

18 Oct 2010

ASTRO honors founder of The Oral Cancer Foundation

The American Society for Radiation Oncology (ASTRO) has named Brian Hill of Newport Beach, Calif., as its 2010 Survivor Circle Award winner. Hill will be recognized with a trophy and a $1,000 prize during the Awards Ceremony on Tuesday, November 2, 2010, during ASTRO's 52nd Annual Meeting in San Diego. He has chosen to donate the funds from the award to benefit The Oral Cancer Foundation, the nonprofit he started a decade ago.

18 Oct 2010

Health law's new patient-centered outcomes board takes shape; More insurance waiver requests expected

The Washington Post reports on a new entity: the Board of Governors of the Patient Centered Outcomes Research Institute. "If you're not familiar with the board, you're not alone. Created by the health-care overhaul law, it's one of the newest and least known panels in government. But the work of its 21 members, if successful, could increase the public's knowledge of medical treatments for everything from attention deficit and hyperactivity disorder to cancer.

18 Oct 2010

The MedTech Conference highlights latest medical technologies

AdvaMed 2010 The MedTech Conference opens on Monday, October 18 with a series of free educational Executive Workshops focused on bringing products to the US markets, a 1/2 day entrepreneur bootcamp, and minimizing risk and global harmonization.

18 Oct 2010

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Novartis announced today that new six-year data reinforce the long-term efficacy and safety profile of once-yearly Reclast (zoledronic acid) injection in postmenopausal women with osteoporosis. The study of more than 1,200 women was presented this weekend at the annual meeting of the American Society for Bone and Mineral Research (ASBMR) in Toronto, ON, Canada.

18 Oct 2010

Teva Pharmaceutical announces new data from PreCISe study

Teva Pharmaceutical Industries Ltd. today announced new data from the five-year extension of the PreCISe study demonstrating that earlier initiation of treatment with Copaxone (glatiramer acetate injection) in patients presenting with first signs of multiple sclerosis (MS), provided greater effects in delaying conversion to clinically definite MS (CDMS) compared to later treatment initiation after diagnosis of CDMS or after three years on the study.

18 Oct 2010

Today's Op-Eds: Critiques of 'Obamacare,' Skyrocketing brand name drug prices, pay-for-performance

People are less negative about some of the specifics than they are about the package as a whole. But does this imply that those who understand the law like it better. Despite their political views, the well-informed share a strong opposition to the new law.

18 Oct 2010

New analysis examines guiding principles for policymakers to fight health care fraud

In light of the recent historic Medicare fraud bust, a new analysis that examines the "Seven Guiding Principles for Policymakers" to fighting health care fraud invites new questions about legislative efforts to reduce accountability and oversight of independent pharmacies, the Pharmaceutical Care Management Association (PCMA) said today.

15 Oct 2010

Neuroprotective properties of laquinimod for RRMS presented at 26th ECTRIMS Congress

Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that data providing further evidence of the neuroprotective properties of laquinimod in animal studies were presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Gothenburg, Sweden.

15 Oct 2010

UnitedHealth proposes managed-care plan for those who get both Medicare and Medicaid

UnitedHealth Group Inc. is proposing a managed-care plan for dual recipients of Medicare and Medicaid.

15 Oct 2010

Abortion, health law heat up campaign debates around the country

Running for re-election, Sen. Barbara Boxer, D-Calif., Thursday charged that Republican Carly Fiorina's stance on abortion is "'a direct threat' to the rights of women in California and the nation ...," the Los Angeles Times reports. "'Overturning Roe vs. Wade would turn women and doctors into criminals,' Boxer said. 'The most extreme anti-choice groups have found their candidate in Carly Fiorina.'

15 Oct 2010

Aetna adds The Washington Hospital to provider network

Aetna announced that it has reached agreement with The Washington Hospital on a contract that adds a new hospital and potentially as many as 200 new physicians to Aetna's provider network in western Pennsylvania.

15 Oct 2010

Watson Laboratories receives FDA approval for Amlodipine capsules

Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate/Benazepril 5/20mg, 10/20mg, 2.5/10mg, and 5/10mg capsules, the generic equivalent to Novartis' Lotrel capsules.

15 Oct 2010

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced the launch of My SPRYCEL (dasatinib) Support, a useful resource to assist adult patients with chronic myeloid leukemia (CML) who are taking SPRYCEL.

15 Oct 2010

CVS Caremark to present client experiences on innovative approaches at AMCP Conference

CVS Caremark is presenting data at the Academy of Managed Care Pharmacy (AMCP) 2010 Educational Conference illustrating how innovative approaches to traditional plan designs can help clients reduce drug spend, improve generic dispensing rates (GDR) and minimize member disruption.

15 Oct 2010

Medicare actuary says changes in advantage plans will mean more cost for some seniors

Politico obtained an analysis by Richard Foster, the actuary for the Centers for Medicare and Medicaid, which that the health law will mean increased costs for seniors in Medicare Advantage plans.

15 Oct 2010

MedSolutions, Corporate Research Group announce initial results from diagnostic accuracy program

MedSolutions and Corporate Research Group today announced initial results from a groundbreaking diagnostic accuracy program, which showed shortened hospital stays, reduced emergency room visits and lower overall medical costs among participants.

15 Oct 2010

New program will cut payment for durable medical equipment in Medicare test program

In California, beginning Jan. 1, "a new Medicare program will slash by 30 percent the prices it will pay for certain wheelchairs, oxygen concentrators and other medical devices in San Bernardino and Riverside counties, lowering costs for both local Medicare recipients and the American taxpayer," Redland Daily Facts reports.

15 Oct 2010

Medicare News and Research

14 global studies on osteoporosis medications FORTEO and EVISTA to be presented at ASBMR 2010

First Edition: October 18, 2010

Politics and health law: Dems' divergent strategies; mixed polls on 'repeal and replace'

ASTRO honors founder of The Oral Cancer Foundation

Health law's new patient-centered outcomes board takes shape; More insurance waiver requests expected

The MedTech Conference highlights latest medical technologies

Six-year data of reinforces efficacy and safety of Reclast injection in postmenopausal women with osteoporosis

Teva Pharmaceutical announces new data from PreCISe study

Today's Op-Eds: Critiques of 'Obamacare,' Skyrocketing brand name drug prices, pay-for-performance

New analysis examines guiding principles for policymakers to fight health care fraud

Neuroprotective properties of laquinimod for RRMS presented at 26th ECTRIMS Congress

UnitedHealth proposes managed-care plan for those who get both Medicare and Medicaid

Abortion, health law heat up campaign debates around the country

Aetna adds The Washington Hospital to provider network

Watson Laboratories receives FDA approval for Amlodipine capsules

Bristol-Myers, Otsuka launch My SPRYCEL Support program to assist patients with CML

CVS Caremark to present client experiences on innovative approaches at AMCP Conference

Medicare actuary says changes in advantage plans will mean more cost for some seniors

MedSolutions, Corporate Research Group announce initial results from diagnostic accuracy program

New program will cut payment for durable medical equipment in Medicare test program

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News